Stock & Company Details
Alcon, Inc. $ALC
Price:
N/A
N/A
N/A
$31B
52 Week High:
N/A
10 Day Average Volume:
N/A
38.05
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ALC technical indicators
Latest Alcon, Inc. (ALC) indicator readings as of 2026-10-09.
ALC's 14-day RSI is 39.4, in neutral territory. At $64.11 it is trading 12.0% below its 200-day moving average of $72.86, and below its 50-day average of $69.00. Price sits in the middle of its Bollinger Bands ($62.34 to $67.44). ADX reads 36.9, indicating a trending market.
ALC backtested strategy results
How 4 rule-based strategies performed on Alcon, Inc. (ALC) over recent history, last backtested 2026-10-07. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +98.7% | 82% | 11 | -16.9% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | -36.1% | 21% | 28 | -45.8% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | -36.2% | 21% | 33 | -43.4% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +39.7% | 65% | 20 | -14.7% |
Overview
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland.
Finance Bot
Ask your questions
Start by typing a question below.
